Multi-portion endoluminal prosthesis

US9498322B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9498322-B2
Application numberUS-54102106-A
CountryUS
Kind codeB2
Filing dateSep 29, 2006
Priority dateMar 31, 2004
Publication dateNov 22, 2016
Grant dateNov 22, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

An endoluminal prosthesis for occluding a dissection of an aorta has a tube with a first portion and a second portion. The second portion of the tube comprises a bioaborbable material. The prosthesis also comprises a stent coupled to the tube. The prosthesis is configured for endoluminal placement in the aorta via an artery.

First claim

Opening claim text (preview).

What is claimed is: 1. An endoluminal prosthesis comprising: a tube having a first portion comprising a first tubular graft material being non-porous and non-bioabsorbable and a second portion comprising a second tubular graft material, said second portion being entirely bioresorbable such that no part of the second portion remains in situ after a period of time from a few weeks to several months thereby providing temporary wound support, wherein the first and second portions are arranged coaxially in series and coupled to one another; and an expandable stent coupled to the tube at the second portion, wherein after bioresorption of the second tubular graft material only the expandable stent remains. 2. The endoluminal prosthesis of claim 1 , wherein second tubular graft material comprises: a copolymer of glycolide and lactide; polyglactin; polyglycolic acid; polyglyconate; or polydioxanone. 3. The endoluminal prosthesis of claim 1 , further comprising a plurality of self-expanding stent elements that are coupled along a length of the first portion of the tube. 4. The endoluminal prosthesis of claim 1 , wherein the stent comprises a plurality of self-expanding stent elements that are coupled along a length of the second portion of the tube. 5. The endoluminal prosthesis of claim 1 , wherein the expandable stent is a self-expanding stent. 6. The endoluminal prosthesis of claim 1 , wherein the second tubular graft material is porous. 7. The endoluminal prosthesis of claim 1 , wherein the non-porous material comprises a derived collagen material. 8. The endoluminal prosthesis of claim 7 , wherein the derived collagen material is an extracellular matrix. 9. The endoluminal prosthesis of claim 8 , wherein the extracellular matrix is: small intestinal submucosa; stomach submucosa; pericardium; liver basement membrane; or urinary bladder submucosa. 10. The endoluminal prosthesis of claim 1 , wherein the first portion of the tube comprises a synthetic material. 11. The endoluminal prosthesis of claim 10 , wherein the synthetic material is a polyester, polytetrafluoroethylene, or expanded polytetrafluoroethylene. 12. The endoluminal prosthesis of claim 1 , wherein the prosthesis is compressible for endoluminal placement in an aorta. 13. An endoluminal prosthesis comprising: a tube having a first portion comprising a first tubular graft material being non-porous and non-bioabsorbable and a second portion comprising a second tubular graft material, said second portion being entirely bioresorbable such that no part of the second portion remains in situ after a period of time from a few weeks to several months thereby providing temporary wound support, wherein the first and second portions are arranged coaxially in series and coupled to one another, wherein second tubular graft material comprises at least one of polyglactin, polyglycolic acid, polyglyconate, polydioxanone and a copolymer of a glycolide and lactide; and an expandable stent coupled to the tube at the second portion, wherein after bioresorption of the second tubular graft material only the expandable stent remains. 14. The endoluminal prosthesis of claim 13 , wherein the stent comprises a plurality of self-expanding stent elements that are coupled along a length of the first portion of the tube. 15. The endoluminal prosthesis of claim 14 , including a plurality of self-expanding stent elements that are coupled along a length of the second portion of the tube. 16. The endoluminal prosthesis of claim 13 , wherein the second tubular graft material is porous. 17. An endoluminal prosthesis comprising: a tube having a first portion comprising a first tubular graft material being non-porous and non-bioabsorbable and a second portion comprising a second tubular graft material, said second portion being entirely bioresorbable such that no part of the second portion remains in situ after a period of time from a few weeks to several months thereby providing temporary wound support, wherein the first and second portions are arranged coaxially in series and coupled to one another, wherein second tubular graft material is porous and comprises at least one of polyglactin, polyglycolic acid, polyglyconate, polydioxanone and a copolymer of a glycolide and lactide; an expandable stent coupled to the tube, wherein the stent comprises a plurality of self-expanding stent elements that are coupled along a length of the first portion of the tube; a second stent coupled to the second portion of the tube, wherein the second stent comprises a plurality of self-expanding stent elements that are coupled along a length of the second portion of the tube, wherein after bioresorption of the second tubular graft material only the plurality of self-expanding stents remain at the second portion of the tube; wherein the non-porous material comprises a derived collagen material, wherein the derived collagen material is an extracellular matrix, and wherein the extracellular matrix is small intestinal submucosa, stomach submucosa, pericardium, liver basement membrane, or urinary bladder submucosa.

Assignees

Inventors

Classifications

  • A61F2/07Primary

    Stent-grafts · CPC title

  • Instruments specially adapted for placement or removal of stents or stent-grafts · CPC title

  • the stent being loosely attached to the graft material, e.g. by stitching · CPC title

  • the wire-like elements comprising two or more adjacent rings flexibly connected by separate members · CPC title

  • the retaining means being filaments or wires · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9498322B2 cover?
An endoluminal prosthesis for occluding a dissection of an aorta has a tube with a first portion and a second portion. The second portion of the tube comprises a bioaborbable material. The prosthesis also comprises a stent coupled to the tube. The prosthesis is configured for endoluminal placement in the aorta via an artery.
Who is the assignee on this patent?
Thomas Barry A, Cook Medical Technologies Llc
What technology area does this patent fall under?
Primary CPC classification A61F2/07. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).